2022 Pneumonia and Diarrhea Progress Report Finds Continued Impact of COVID-19 Pandemic and Stalled Progress
For over 10 years, IVAC’s annual Pneumonia & Diarrhea Progress Report has tracked the progress against two of the leading killers of children worldwide: pneumonia and diarrhea. This year’s report highlights the ongoing impacts of the COVID-19 pandemic on achieving targets for progress in child health. Along with the annual report, IVAC is debuting 15 country data visualization profiles that highlight where progress has advanced and where it has stalled.
Each year we evaluate the progress across 10 key indicators outlined in the Global Action Plan for the Prevention and Control of Pneumonia and Diarrhea (GAPPD) in the 15 countries with the greatest burden of pneumonia and diarrhea deaths in children under 5. |
 |
|
IVAC Webinar Series: Wednesday, November 9, 11:00 am EST
The Future of Pneumonia Prevention: Building on the Success of Vaccines
The COVID-19 pandemic has led to major backsliding for childhood vaccinations with many of the world’s most vulnerable populations underimmunized or not receiving any life-saving immunizations at all. Use of pneumococcal conjugate vaccines (PCV) is one of the most effective interventions for preventing pneumonia deaths among children under five and countries have struggled to achieve universal coverage and reach at-risk communities even before the onset of a global pandemic. For this year’s World Pneumonia Day, IVAC has gathered a diverse panel of experts to discuss the implications of observed declines in PCV coverage and to explore promising approaches or strategies to expand PCV delivery from the lenses of epidemiology, health economics, and implementation science. We hope you will join us for this interdisciplinary panel coming together to share valuable insights about the path forward to restore, maintain and expand PCV coverage.
Panelists:
- Dr. Chizoba Wonodi, International Vaccine Access Center (Moderator)
- Dr. Annick Sidibe, Jhpiego (Burkina Faso)
- Dr. Lulu Bravo, College of Medicine, University of the Philippines Manila
- Dr. Ruth Jimbo-Sotomayor, Pontificia Universidad Católica del Ecuador
- Dr. Ruth Lucinde, KEMRI-Wellcome Trust (Kenya)
|
 |
|
Webinar: Fighting Pneumonia: An Agenda for Action
November 14th at 12:00pm - 13:35pm CET (Paris Time) Register Here
The Fondation Mérieux and Every Breath Counts Coalition are co-hosting a critical conversation on what governments and international agencies must do to reduce pneumonia deaths and the risk of future respiratory pandemics – for more information on this event please check their website. |
 |
|
| Pneumococcal Vaccine Resources |
|
|
Widespread Adoption of PCVs Key to Reducing Pneumonia-Related Childhood Deaths
Pneumonia is among the leading infectious causes of global childhood deaths, with the highest burden observed in the world’s poorest countries. Ensuring widespread adoption of pneumococcal conjugate vaccines (PCVs) through enabling their introduction in national immunization programs is critical to reducing pneumonia-related deaths in children and meeting global health targets. Leading up to World Pneumonia Day 2022, there remain 30 countries that have not yet introduced PCVs, 28 of which are low- and middle-income countries. |
|
|
| IVAC’s Global Advocacy for PCV (GAP) project is focusing on these countries to support advocacy activities to close the global PCV introduction gap. One of the countries that the GAP project is focusing on is Somalia, where pneumonia accounts for a quarter of all child deaths each year. The estimated number of illnesses caused by Streptococcus pneumoniae or pneumococcus, such as pneumonia or meningitis, is thought to be upwards of 93,000 annually, a staggeringly high rate in a country of 15 million people (source: VIEW-hub). Stakeholders from Somalia and Somaliland are determined to change the status quo. |
|
|
VIEW-hub Visualizes Vaccine Access
VIEW-hub, a map-based platform for visualizing data on vaccine use and impact, hosts resources and maps on PCV immunization introduction, access, coverage, impact, and outcomes. |
 |
|
|
|
Immunization Agenda 2030: World Pneumonia Day Toolkit
The pneumococcal conjugate vaccine is an effective strategy for stopping child pneumonia. Let’s work together to ensure that the IA2030 global goal of a 90% PCV3 vaccination coverage is reached.
Spread the word and download social media graphics and messages from the IA2030 Scorecard toolkit.
|
|
 |
|
|
|
|
|
|
